Literature DB >> 525930

Role of mixed-function oxidase in 3-methylindole-induced acute pulmonary edema in goats.

T M Bray, J R Carlson.   

Abstract

The relationship between the pulmonary toxicity of 3- methylindole (3MI, skatole) and the mixed-function oxidase (MFO) system was investigated. Nine goats assigned to three groups were given a jugular infusion of [14C]3MI (0.02 to 0.03 g of 3MI/kg of body weight containing 0.5 muCi/kg of body weight) for 1.5 hours to induce acute pulmonary edema. Two groups of three goats each were treated with phenobarbital (PB) or piperonyl butoxide (BT) prior to 3MI infusion to induce or to inhibit the MFO system. Three goats were used as 3MI controls. During a 72-hour test period, blood was collected for determination of plasma 3MI concentration and radioactivity. Urine was collected and was fractionated by column chromatography. The severity of pulmonary lesions was evaluated by gross and microscopic examination. Pretreatment with BT prevented the onset of acute pulmonary edema. Goats pretreated with PB had more severe lung lesions than did 3MI controls. Plasma of goats pretreated with BT had a longer half-life (2.1 hours) of radioactivity, whereas plasma of goats pretreated with PB had a shorter half-life (1.0 hour) when compared with plasma of 3MI control goats (1.5 hours) given the same dosage of [14C]3MI (P less than 0.025). The plasma half-life of 3MI was longer (P less than 0.025) in BT-pretreated goats (0.45 hour) than that in PB-pretreated goats (0.26 hour). At 72 hours, 70% to 98% of the infused radioactivity had been excreted in the urine. The pattern of urinary metabolites of 3MI was altered in BT-pretreated goats compared with patterns in control and PB-pretreated goats. Results indicate that the MFO system is one of the pathways involved in the metabolism of 3MI and that pulmonary toxicosis results from metabolism of 3MI by this enzyme system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525930

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

Review 1.  Lung surfactant and pulmonary toxicology.

Authors:  H P Haagsman; L M van Golde
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Pulmonary lesions induced by 3-methylindole in mice.

Authors:  S K Durham; W L Castleman
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

3.  Effect of melengestrol acetate on development of 3-methylindole-induced pulmonary edema and emphysema in sheep.

Authors:  J D Popp; T A McAllister; J P Kastelic; W Majak; M Ayroud; M A VanderKop; D Karren; G S Yost; K J Cheng
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

4.  Pathologic changes in 3-methylindole-induced equine bronchiolitis.

Authors:  M A Turk; R G Breeze; A M Gallina
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

5.  Ultrastructural changes in intraacinar pulmonary veins. Relationship to 3-methylindole-induced acute pulmonary edema and pulmonary arterial changes in cattle.

Authors:  O S Atwal; M S Persofsky
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

6.  The effect of 3-methylindole on the uptake and incorporation of 14C-choline into phospholipids in lung tissue slices.

Authors:  J B Kirkland; T M Bray
Journal:  Lipids       Date:  1984-10       Impact factor: 1.880

7.  Ultrastructural pulmonary changes induced by intravenously administered 3-methylindole in goats.

Authors:  B J Bradley; J R Carlson
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

8.  Glycogen accumulation in alveolar type II cells in 3-methylindole--induced pulmonary edema in goats.

Authors:  O S Atwal; T M Bray
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

9.  Involvement of free radicals in the mechanism of 3-methylindole-induced pulmonary toxicity: an example of metabolic activation in chemically induced lung disease.

Authors:  T M Bray; S Kubow
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.